About this trial
This study is to evaluate the sensitivity and intra-/inter-observer agreement of the averaged magnetization inversion recovery acquisitions (AMIRA) in spinal cord (SC) Multiple sclerosis (MS) lesion detection and to evaluate the additional clinical value of this sequence in clinical settings.
Eligibility criteria
Qualifiers
Diagnosis of multiple sclerosis according to established international criteria
Steroid free period: > 4 weeks
Participation in the Swiss MS Cohort (SMSC) study
Disqualifiers
. History of severe (other) neurological, internal or psychiatric disease with SC affection
Paramagnetic and/or superparamagnetic foreign objects in the body (especially when located close to the SC)
Pacemaker
Claustrophobia
Trial design
Treatments tested in this trial
- SC MRI
- patient questionnaire
Treatment groups
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
Freie Akademische Gesellschaft Basel
Collaborator